Computational Biology
SKU
MRR-433AB1DC289D
Region
Global
Publication Date
February 2024
Delivery
Immediate
2023
USD 6.25 billion
2030
USD 21.01 billion
2024
USD 7.42 billion
CAGR
18.91%

Computational Biology Market by Services (Contract, In-house), Application (Cellular Biological Simulation, Clinical Trials, Drug Discovery & Disease Modelling), End-Use - Global Forecast 2024-2030

[193 Pages Report] The Computational Biology Market size was estimated at USD 6.25 billion in 2023 and expected to reach USD 7.42 billion in 2024, at a CAGR 18.91% to reach USD 21.01 billion by 2030.

Computational Biology Market
To learn more about this report, request a free PDF copy

Computational biology is an interdisciplinary domain that applies techniques from computer science, applied mathematics, statistics, and bioinformatics to solve complex problems in biology, understand biological data, and model biological systems. It encompasses the development and application of theoretical methods and data-analytical, computational simulation techniques, and mathematical modeling to the study of biological, behavioral, and social systems. The primary aim of this technology is to generate insights into the principles and dynamics of biological systems, as well as to predict their behaviors and interactions. Computational biology is closely related to the field of bioinformatics but tends to focus more on the development of theoretical approaches and computational models. The computational biology market is driven by the increasing need for drug discovery and personalized medicine, advancements in the field of bioinformatics, and the rise in the volume of complex biological data. Government and private funding for research and development in genomics and proteomics also support the market expansion. Despite growth prospects, the need for specialized computational infrastructure, high costs associated with computational tools, and a shortage of skilled professionals to analyze biological data hinder the scope of computational biology. Moreover, concerns regarding data security and privacy and the complexity of regulatory compliances for healthcare-related data create hurdles in market proliferation. However, an integration of artificial intelligence and machine learning algorithms is further presenting lucrative opportunities for market growth by enhancing predictive modeling and data analysis capabilities. Moreover, the rising focus on biomarker discovery and its role in precision medicine opens up new opportunities for the market's expansion.

Computational Biology Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
Services: Benefits of in-house computational biology capabilities to handle sensitive data or proprietary research

In the dynamic field of computational biology, contract based services stand out as a flexible solution for organizations seeking specialized expertise without the overhead of full-time employment. These services, offered by external providers or individual consultants, are tailored to meet the specific project demands and timelines, making them an invaluable resource for companies that require advanced analytical skills, state-of-the-art algorithm development, or custom bioinformatics software solutions on a temporary or per-project basis. In contrast, in-house computational biology services are integrated within an organization's permanent operational structure. This approach allows for a consistent and long-term investment in computational biology expertise, fostering a deep understanding of the company's specific research areas and methodologies. In-house teams are intimately familiar with the data, objectives, and processes of their organization, enabling them to align their output closely with the strategic goals of the business. They provide a stable and continually evolving resource capable of adapting to the company's changing needs over time.

Application: Significant applications of computational biology to streamline the drug development pipeline

Cellular biological simulation involves the use of computational models to simulate the behaviors and interactions of biological cells. These simulations help to understand and predict cellular functions, biological behaviors, and responses to various stimuli, which is critical for both basic research and applied biomedical applications. The technology is especially relevant for investigating complex biochemical pathways and in silico experimentation, which can be cost-prohibitive or technically challenging to perform in vitro or in vivo. Clinical trials are experimental research studies conducted to determine the efficacy of new drugs, medical devices, or treatment protocols on human subjects. Computational biology plays a pivotal role in the design and analysis of clinical trials, improving the efficiency of trial designs, patient stratification, and data analysis. Drug discovery & disease modeling are crucial applications of computational biology where computer-aided design (CAD) for drug compounds and modeling of disease pathways accelerate the discovery of new therapeutics. These methods enable the exploration of vast chemical spaces and the modeling of complex diseases, respectively, to identify potential targets and molecules for new drugs. Human body simulation software encompasses a broad set of computational tools designed to model anatomical and physiological aspects of the human body. These simulations are employed for a variety of applications, including medical device design, surgical planning, and educational purposes. Preclinical drug development is the phase of research that precedes clinical trials in the drug development process. It involves the use of in silico models and simulation tools to predict the pharmacokinetics, pharmacodynamics, and toxicity of candidate drugs.

End-Use: Growing adoption of computational biology in commercial entities to tackle applied research challenges

In academic settings, computational biology tools are primarily used for research and educational purposes. The emphasis is on accessibility to cutting-edge technology, ease of use for students and researchers, and cost-effectiveness. Academic institutions often require extensive databases and computational power for diverse research ranging from evolutionary biology to systems biology. Commercial entities, including pharmaceutical and biotech companies, prioritize the application of computational biology for drug discovery and development, personalized medicine, and agrigenomics. These sectors seek robust, scalable solutions with a strong emphasis on data security and intellectual property protection.

Regional Insights

The computational biology market in the Americas, particularly in North America, is exhibiting robust growth. The presence of established pharmaceutical companies, sophisticated healthcare infrastructure, and rigorous research and development activities are propelling the region's market expansion. Large-scale investments in genomics and proteomics are further spurring demand for computational biology solutions. The United States remains at the forefront, backed by supportive government policies, substantial academic-industry collaborations, and an increase in bioinformatics-related courses that supply skilled professionals to the field. The EMEA region has been experiencing a significant surge in the computational biology market owing to increased funding by private and public entities, particularly in Europe. Efficient regulatory frameworks for drug development and a tradition of excellence in scientific research are driving the market's progress in this region. Germany, the UK, and France are major contributors with their strong focus on biotechnology and computational sciences. The Middle East is steadily catching up, largely due to strategic government investments in the biotech sector, while Africa is in the early stages of development. Asia-Pacific is emerging as a dynamic growth hub for the computational biology market. Rapid economic development, increasing healthcare expenditure, and a burgeoning biotechnology industry characterize the market landscape. Countries in the region are providing lucrative opportunities for market players owing to governmental backing, a focus on education and research in the life sciences, and a rising emphasis on personalized medicine. Cross-border collaborations and the inflow of foreign investments are further defining this market, positioning APAC as a competitive and high-potential region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Computational Biology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Computational Biology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • New Funds Available for Early Career Canadian Researchers Building Careers in Bioinformatics, Computational Biology, or Health Data Sciences

    Genome Canada announced its collaboration with the Canadian Institutes of Health Research (CIHR), specifically with the Institutes of Aging, Cancer Research, Genetics, Infection and Immunity, and Musculoskeletal Health and Arthritis, in launching the 2024/25 Health Research Training Platform (HRTP). This initiative, bolstered by partnerships with the Centre for Research on Pandemic Preparedness and Health Emergencies and Mitacs, aims to nurture a diverse group of trainees and early career researchers through interdisciplinary training platforms. With a commitment of USD 6,050,000 for the bioinformatics, computational biology, and health data sciences pool, these funds are dedicated to offering substantial support to a single project that demonstrates potential for profound impact. [Published On: 2023-10-13]

  • Pluto Announces USD 3.7M Seed Round, Led by Silverton Partners

    Pluto announced a significant milestone with the completion of a USD 3.7 million seed financing round, led by Silverton Partners, aimed at propelling the evolution of biological data assessment and multiplying the pace of discoveries within the life sciences domain globally. Boasting an intuitive web-based interface, Pluto's computational biology platform is at the forefront of enhancing researcher capability in the analysis, visualization, and interpretation of complex biological information. [Published On: 2023-05-02]

  • Accenture Invests in Ocean Genomics to Accelerate AI-driven Drug Discovery and the Development of Personalized Medicines

    Accenture PLC has strategically enhanced its technological footprint through an investment in Ocean Genomics via Accenture Ventures' Project Spotlight. Ocean Genomics specializes in computational platforms powered by artificial intelligence, revolutionizing the biopharmaceutical sector's approach to diagnostics and drug development. Their innovative solutions delve into the intricate world of mRNA, enabling the prediction of individual responses to medical treatments with greater accuracy. [Published On: 2023-02-16]

Key Company Profiles

The report delves into recent significant developments in the Computational Biology Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., BGI Group, Biomax Informatics AG, Chemical Computing Group Inc., Compugen Ltd., Dassault Systèmes SE, DNAnexus, Inc., DNASTAR, Inc., Eurofins Scientific SE, Genedata AG, Illumina, Inc., Insilico Medicine, Instem Group, Nimbus Discovery Llc, Ocean Genomics, PerkinElmer, Inc., Pluto Bioinformatics, ProFound Therapeutics, QIAGEN N.V., Rosa & Co. Llc, Schrodinger, Inc., Simulation Plus Inc., SOPHiA GENETICS, Thermo Fisher Scientific Inc., Waters Corporation, and WuXi NextCODE.

Market Segmentation & Coverage

This research report categorizes the Computational Biology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Services
    • Contract
    • In-house
  • Application
    • Cellular Biological Simulation
    • Clinical Trials
    • Drug Discovery & Disease Modelling
    • Human Body Simulation Software
    • Preclinical Drug Development
  • End-Use
    • Academics
    • Commercial

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Computational Biology Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Computational Biology Market?
  3. What are the technology trends and regulatory frameworks in the Computational Biology Market?
  4. What is the market share of the leading vendors in the Computational Biology Market?
  5. Which modes and strategic moves are suitable for entering the Computational Biology Market?

Table of Contents
  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research Methodology
    1. Define: Research Objective
    2. Determine: Research Design
    3. Prepare: Research Instrument
    4. Collect: Data Source
    5. Analyze: Data Interpretation
    6. Formulate: Data Verification
    7. Publish: Research Report
    8. Repeat: Report Update
  3. Executive Summary
  4. Market Overview
  5. Market Insights
    1. Market Dynamics
      1. Drivers
        1. Rising Need for Personalized Medicine
        2. Growing Bioinformatics Research and Increasing Number of Clinical Studies
        3. Adoption of Computational Biology in Oncology Therapeutics
      2. Restraints
        1. Dearth of Skilled Professionals to Operate Computational Tools
      3. Opportunities
        1. Accelerating Use of Bioinformatics and Multiscale Biological Modeling in Cell Modeling
        2. Increased Funding in Bioinformatics Coupled with Advancements in the Field of Computational Biology
      4. Challenges
        1. Insufficiency of Interoperability and Multiplatform Capabilities and Lack of Well-Defined Standards
    2. Market Segmentation Analysis
      1. Services: Benefits of in-house computational biology capabilities to handle sensitive data or proprietary research
      2. Application: Significant applications of computational biology to streamline the drug development pipeline
      3. End-Use: Growing adoption of computational biology in commercial entities to tackle applied research challenges
    3. Market Trend Analysis
    4. Cumulative Impact of Russia-Ukraine Conflict
    5. Cumulative Impact of High Inflation
    6. Porter’s Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    7. Value Chain & Critical Path Analysis
    8. Regulatory Framework
    9. Client Customization
  6. Computational Biology Market, by Services
    1. Introduction
    2. Contract
    3. In-house
  7. Computational Biology Market, by Application
    1. Introduction
    2. Cellular Biological Simulation
    3. Clinical Trials
    4. Drug Discovery & Disease Modelling
    5. Human Body Simulation Software
    6. Preclinical Drug Development
  8. Computational Biology Market, by End-Use
    1. Introduction
    2. Academics
    3. Commercial
  9. Americas Computational Biology Market
    1. Introduction
    2. Argentina
    3. Brazil
    4. Canada
    5. Mexico
    6. United States
  10. Asia-Pacific Computational Biology Market
    1. Introduction
    2. Australia
    3. China
    4. India
    5. Indonesia
    6. Japan
    7. Malaysia
    8. Philippines
    9. Singapore
    10. South Korea
    11. Taiwan
    12. Thailand
    13. Vietnam
  11. Europe, Middle East & Africa Computational Biology Market
    1. Introduction
    2. Denmark
    3. Egypt
    4. Finland
    5. France
    6. Germany
    7. Israel
    8. Italy
    9. Netherlands
    10. Nigeria
    11. Norway
    12. Poland
    13. Qatar
    14. Russia
    15. Saudi Arabia
    16. South Africa
    17. Spain
    18. Sweden
    19. Switzerland
    20. Turkey
    21. United Arab Emirates
    22. United Kingdom
  12. Competitive Landscape
    1. Market Share Analysis, 2023
    2. FPNV Positioning Matrix, 2023
    3. Competitive Scenario Analysis
      1. New Funds Available for Early Career Canadian Researchers Building Careers in Bioinformatics, Computational Biology, or Health Data Sciences
      2. Pluto Announces USD 3.7M Seed Round, Led by Silverton Partners
      3. Accenture Invests in Ocean Genomics to Accelerate AI-driven Drug Discovery and the Development of Personalized Medicines
  13. Competitive Portfolio
    1. Key Company Profiles
    2. Key Product Portfolio
  14. List of Figures [Total: 22]
    1. COMPUTATIONAL BIOLOGY MARKET RESEARCH PROCESS
    2. COMPUTATIONAL BIOLOGY MARKET SIZE, 2023 VS 2030
    3. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
    4. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    5. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    6. COMPUTATIONAL BIOLOGY MARKET DYNAMICS
    7. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
    8. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
    9. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
    10. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
    11. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
    12. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
    13. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    14. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    15. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    16. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    17. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    18. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    19. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    20. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    21. COMPUTATIONAL BIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
    22. COMPUTATIONAL BIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
  15. List of Tables [Total: 286]
    1. COMPUTATIONAL BIOLOGY MARKET SEGMENTATION & COVERAGE
    2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
    3. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2023 (USD MILLION)
    4. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, 2024-2030 (USD MILLION)
    5. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
    6. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
    7. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    8. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    9. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT, BY REGION, 2018-2023 (USD MILLION)
    10. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT, BY REGION, 2024-2030 (USD MILLION)
    11. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY IN-HOUSE, BY REGION, 2018-2023 (USD MILLION)
    12. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY IN-HOUSE, BY REGION, 2024-2030 (USD MILLION)
    13. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    14. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    15. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CELLULAR BIOLOGICAL SIMULATION, BY REGION, 2018-2023 (USD MILLION)
    16. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CELLULAR BIOLOGICAL SIMULATION, BY REGION, 2024-2030 (USD MILLION)
    17. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2023 (USD MILLION)
    18. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2024-2030 (USD MILLION)
    19. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY & DISEASE MODELLING, BY REGION, 2018-2023 (USD MILLION)
    20. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY & DISEASE MODELLING, BY REGION, 2024-2030 (USD MILLION)
    21. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY HUMAN BODY SIMULATION SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
    22. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY HUMAN BODY SIMULATION SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
    23. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRECLINICAL DRUG DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
    24. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRECLINICAL DRUG DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
    25. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    26. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    27. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMICS, BY REGION, 2018-2023 (USD MILLION)
    28. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMICS, BY REGION, 2024-2030 (USD MILLION)
    29. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2023 (USD MILLION)
    30. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY COMMERCIAL, BY REGION, 2024-2030 (USD MILLION)
    31. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    32. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    33. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    34. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    35. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    36. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    37. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    38. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    39. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    40. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    41. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    42. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    43. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    44. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    45. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    46. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    47. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    48. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    49. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    50. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    51. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    52. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    53. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    54. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    55. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    56. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    57. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    58. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    59. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    60. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    61. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    62. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    63. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    64. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    65. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    66. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    67. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    68. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    69. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
    70. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
    71. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    72. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    73. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    74. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    75. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    76. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    77. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    78. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    79. AUSTRALIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    80. AUSTRALIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    81. AUSTRALIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    82. AUSTRALIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    83. AUSTRALIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    84. AUSTRALIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    85. CHINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    86. CHINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    87. CHINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    88. CHINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    89. CHINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    90. CHINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    91. INDIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    92. INDIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    93. INDIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    94. INDIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    95. INDIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    96. INDIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    97. INDONESIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    98. INDONESIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    99. INDONESIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    100. INDONESIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    101. INDONESIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    102. INDONESIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    103. JAPAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    104. JAPAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    105. JAPAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    106. JAPAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    107. JAPAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    108. JAPAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    109. MALAYSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    110. MALAYSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    111. MALAYSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    112. MALAYSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    113. MALAYSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    114. MALAYSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    115. PHILIPPINES COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    116. PHILIPPINES COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    117. PHILIPPINES COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    118. PHILIPPINES COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    119. PHILIPPINES COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    120. PHILIPPINES COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    121. SINGAPORE COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    122. SINGAPORE COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    123. SINGAPORE COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    124. SINGAPORE COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    125. SINGAPORE COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    126. SINGAPORE COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    127. SOUTH KOREA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    128. SOUTH KOREA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    129. SOUTH KOREA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    130. SOUTH KOREA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    131. SOUTH KOREA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    132. SOUTH KOREA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    133. TAIWAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    134. TAIWAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    135. TAIWAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    136. TAIWAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    137. TAIWAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    138. TAIWAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    139. THAILAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    140. THAILAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    141. THAILAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    142. THAILAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    143. THAILAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    144. THAILAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    145. VIETNAM COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    146. VIETNAM COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    147. VIETNAM COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    148. VIETNAM COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    149. VIETNAM COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    150. VIETNAM COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    151. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    152. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    153. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    154. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    155. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    156. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    157. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    158. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    159. DENMARK COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    160. DENMARK COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    161. DENMARK COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    162. DENMARK COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    163. DENMARK COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    164. DENMARK COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    165. EGYPT COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    166. EGYPT COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    167. EGYPT COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    168. EGYPT COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    169. EGYPT COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    170. EGYPT COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    171. FINLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    172. FINLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    173. FINLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    174. FINLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    175. FINLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    176. FINLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    177. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    178. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    179. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    180. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    181. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    182. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    183. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    184. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    185. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    186. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    187. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    188. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    189. ISRAEL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    190. ISRAEL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    191. ISRAEL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    192. ISRAEL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    193. ISRAEL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    194. ISRAEL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    195. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    196. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    197. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    198. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    199. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    200. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    201. NETHERLANDS COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    202. NETHERLANDS COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    203. NETHERLANDS COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    204. NETHERLANDS COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    205. NETHERLANDS COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    206. NETHERLANDS COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    207. NIGERIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    208. NIGERIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    209. NIGERIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    210. NIGERIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    211. NIGERIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    212. NIGERIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    213. NORWAY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    214. NORWAY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    215. NORWAY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    216. NORWAY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    217. NORWAY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    218. NORWAY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    219. POLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    220. POLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    221. POLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    222. POLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    223. POLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    224. POLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    225. QATAR COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    226. QATAR COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    227. QATAR COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    228. QATAR COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    229. QATAR COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    230. QATAR COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    231. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    232. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    233. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    234. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    235. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    236. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    237. SAUDI ARABIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    238. SAUDI ARABIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    239. SAUDI ARABIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    240. SAUDI ARABIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    241. SAUDI ARABIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    242. SAUDI ARABIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    243. SOUTH AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    244. SOUTH AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    245. SOUTH AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    246. SOUTH AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    247. SOUTH AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    248. SOUTH AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    249. SPAIN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    250. SPAIN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    251. SPAIN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    252. SPAIN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    253. SPAIN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    254. SPAIN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    255. SWEDEN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    256. SWEDEN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    257. SWEDEN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    258. SWEDEN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    259. SWEDEN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    260. SWEDEN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    261. SWITZERLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    262. SWITZERLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    263. SWITZERLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    264. SWITZERLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    265. SWITZERLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    266. SWITZERLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    267. TURKEY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    268. TURKEY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    269. TURKEY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    270. TURKEY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    271. TURKEY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    272. TURKEY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    273. UNITED ARAB EMIRATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    274. UNITED ARAB EMIRATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    275. UNITED ARAB EMIRATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    276. UNITED ARAB EMIRATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    277. UNITED ARAB EMIRATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    278. UNITED ARAB EMIRATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    279. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
    280. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
    281. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    282. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    283. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
    284. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
    285. COMPUTATIONAL BIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
    286. COMPUTATIONAL BIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
  16. List of Companies Mentioned [Total: 26]
    1. Agilent Technologies, Inc.
    2. BGI Group
    3. Biomax Informatics AG
    4. Chemical Computing Group Inc.
    5. Compugen Ltd.
    6. Dassault Systèmes SE
    7. DNAnexus, Inc.
    8. DNASTAR, Inc.
    9. Eurofins Scientific SE
    10. Genedata AG
    11. Illumina, Inc.
    12. Insilico Medicine
    13. Instem Group
    14. Nimbus Discovery Llc
    15. Ocean Genomics
    16. PerkinElmer, Inc.
    17. Pluto Bioinformatics
    18. ProFound Therapeutics
    19. QIAGEN N.V.
    20. Rosa & Co. Llc
    21. Schrodinger, Inc.
    22. Simulation Plus Inc.
    23. SOPHiA GENETICS
    24. Thermo Fisher Scientific Inc.
    25. Waters Corporation
    26. WuXi NextCODE
Cloud-based computational biology platforms: a new jackpot for scientists
April 16, 2023
INSIGHT
Cloud-based computational biology platforms: a new jackpot for scientists
Bioinformatics has seen new developments in recent years, with ML, AI, high-performance cloud computing, and big data processing enabling more applications of computational biology beyond laboratory environments.

Computational biology is the science that gives answer to the question, “How can we learn and use models & algorithms of biological systems constructed from experimental measurements?”

Improvements in drug development processes continuously reduce the time required for a formulation to go from being a candidate to becoming a market-ready product. Speed is especially important in cases such as the development of the COVID-19 vaccine.

The process of drug development requires intensive research, analytics, and clinical trials while meeting regulatory compliance, resulting in lengthy and complex development processes with high uncertainty in cost. Computational platforms can eliminate these issues and assist drugmakers in end-to-end drug development.

Innovators are also introducing a cloud bioinformatics platform for antibody & peptide screening and drug development. It contains a range of features such as sequence editing and annotation, sample clustering and comparison, database management, workflow automation, and detailed reports.

The ongoing innovations in cloud-based platforms are becoming the cherry on top for scientists to perform phage display panning, automate hybridoma analysis, and much more. In this way, scientists and researchers are able to perform computationally intensive tasks from anywhere and at any time through cloud computing.

Computational Biology: Transforming Personalized Medicine
October 25, 2023
BLOG
Computational Biology: Transforming Personalized Medicine
The healthcare industry has experienced a paradigm shift in the last few years, with personalized medicine increasingly becoming popular. The traditional "one size fits all" approach to treating patients is becoming ineffective, and healthcare providers are now considering individualized diagnosis and treatments. The growing need for personalized medicine owes credit to the rise of computational biology, a field encompassing three disciplines: computer science, statistics, and biology. This blog aims to explore the ways in which computational biology is revolutionizing personalized medicine.

Improved Identification of Biomarkers:

One of the essential uses of computational biology in personalized medicine is biomarker identification. Biomarkers refer to biological molecules (such as proteins, DNA, and RNA) that point to a particular disease or condition. Genomics and proteomics research rely heavily on computational biology to identify potential biomarkers and understand their functions. Unlike traditional laboratory techniques, computational biology can analyze vast amounts of data accurately, thus identifying biomarkers with higher precision. Once the biomarker is identified, clinicians can develop personalized treatments tailored to an individual's unique genetic makeup.

Drug Discovery and Development:

Computational biology also plays a significant role in drug discovery and development. Traditional laboratory experiments are often time-consuming and expensive, requiring many resources, such as chemicals and human trials. However, using computational biology models, simulations, and artificial intelligence, researchers can predict the effectiveness of a drug faster and cheaper. This technology speeds up the drug discovery process, benefiting patients who depend on these drugs.

Understanding Disease Mechanisms:

Computational biology helps researchers and clinicians better understand a disease's complexity and underlying mechanisms. It enables the integration of large volumes of genomic, proteomic, and metabolomic data, providing a comprehensive view of the disease. It allows clinicians to pinpoint specific genes and proteins contributing to a condition, thus developing personalized treatments addressing the disease's underlying cause. Computational biology, therefore, facilitates the development of individualized medicine, ensuring better outcomes for patients.

Predictive Diagnostics:

In addition to identifying biomarkers and understanding the mechanisms of diseases, computational biology can predict an individual's risk of specific diseases. Predictive models can identify individuals at risk of developing a disease by analyzing a patient's medical history, genomic data, and other relevant data sets. Clinicians can then implement preventive measures, such as preventative medication and lifestyle changes, to mitigate the disease's development.

Precision Oncology:

Computational biology is helping drive the current trend of precision oncology, where clinicians tailor cancer treatments to a person's genes, proteins, and other biomarkers. By analyzing genomic data and other biomarkers in cancer patients, clinicians can focus on identifying specific mutations that drive cancer development. Precision oncology offers a more targeted and effective approach to treating cancer, offering patients better health outcomes.

Computational biology is transforming the way healthcare providers diagnose, treat, and prevent diseases. Personalized medicine, a rapidly growing field, relies on computational biology to identify biomarkers, predict diseases, develop targeted treatments, and understand disease mechanisms. By integrating artificial intelligence and data analytics, clinicians and researchers can gain insights into vast genomic and proteomic data volumes, leading to more effective and individualized treatments. Computational biology will continue to play an essential role in transforming medicine, ensuring better outcomes for patients.

Frequently Asked Questions
  1. How big is the Computational Biology Market?
    Ans. The Global Computational Biology Market size was estimated at USD 6.25 billion in 2023 and expected to reach USD 7.42 billion in 2024.
  2. What is the Computational Biology Market growth?
    Ans. The Global Computational Biology Market to grow USD 21.01 billion by 2030, at a CAGR of 18.91%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.